U.S. Department of the Air Force, Air Mobility Command announces the availability of funding for a contractor to provide multi-gene testing services for the David Grant Medical Center in California. Services include clinically validated laboratory test, Oncotype DX, the first and only diagnostic multi-gene expression test service commercially available for patients with early-stage node-negative, estrogen receptor positive breast cancer that has clinical evidence validating its ability to perform the likelihood of breast cancer recurrence, likelihood of survival within 10 years of diagnosis and the likelihood of chemo therapy benefit . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | July 25, 2014

Federal Government Announces Multi-Gene Testing Services Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member